HuGE Literature Finder
|
||
Records 1-32
|
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50?years.
Breast cancer research : BCR 2019 May 21 (1): 58. Petridis Christos, Arora Iteeka, Shah Vandna, Megalios Anargyros, Moss Charlotte, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
|
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Molecular genetics & genomic medicine 2019 Jan . Liu Yan, Ide Yoshimi, Inuzuka Mayuko, Tazawa Sakiko, Kanada Yoko, Matsunaga Yuki, Kuwayama Takashi, Sawada Terumasa, Akashi-Tanaka Sadako, Nakamura Sei |
|
Intensive surveillance with bi-annual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Aug . Guindalini Rodrigo Santa, Zheng Yonglan, Abe Hiroyuki, Whitaker Kristen, Yoshimatsu Toshio F, Walsh Tom, Schacht David, Kulkarni Kirti, Sheth Deepa, Verp Marion S, Bradbury Angela R, Churpek Jane, Obeid Elias, Mueller Jeffery, Khramtsova Galina F, Liu Fang, Raoul Akila, Cao Hongyuan, Romero Iris L, Hong Susan, Livingston Robert J, Jaskowiak Nora, Wang Xiaoming, Debiasi Marcio, Pritchard Colin C, King Mary-Claire, Karczmar Gregory S, Newstead Gillian M, Huo Dezheng, Olopade Olufunmilayo |
|
Chronic Pancreatitis-Like Change in BRCA2 Mutation Carriers.
Pancreas 2017 Apr . Mizrahi Meir, Tseng Jennifer F, Wong Daniel, Tung Nadine, Eskander Mariam F, Berzin Tyler M, Pleskow Douglas K, Sawhney Mandeep |
|
Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2017 Mar . Krammer Julia, Pinker-Domenig Katja, Robson Mark E, Gönen Mithat, Bernard-Davila Blanca, Morris Elizabeth A, Mangino Debra A, Jochelson Maxine |
|
A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.
Gynecologic oncology 2014 Sep 134 (3): 492-7. Cass Ilana, Walts Ann E, Barbuto Denise, Lester Jenny, Karlan Be |
|
Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry.
Journal of breast cancer 2014 Jun 17 (2): 129-35. Yu Jong-Han, Lee Jong Won, Son Byung Ho, Kim Sung-Won, Park Sue K, Lee Min Hyuk, Kim Lee Su, Noh Woo-Chul, Kim Eun-Kyu, Yoon Dae Sung, Lee Jeeyeon, Jung Jin Hyang, Jung Sang Seol, Gong Gyungyup, Ahn Sei-Hy |
|
Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2.
Cancer 2014 May 120 (10): 1557-64. Jackson Sarah A, Davis Andrew A, Li Jun, Yi Nengjun, McCormick Shelley R, Grant Carly, Fallen Taya, Crawford Beth, Loranger Kate, Litton Jennifer, Arun Banu, Vande Wydeven Kimberly, Sidani Amer, Farmer Katie, Sanders Merideth, Hoskins Kent, Nussbaum Robert, Esserman Laura, Garber Judy E, Kaklamani Virginia G, |
|
Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria.
Clinical genetics 2014 Jan 85 (1): 72-5. Singer C F, Muhr D, Rappaport C, Tea M-K, Gschwantler-Kaulich D, Fink-Retter A, Pfeiler G, Berger A, Sun P, Narod S |
|
Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal.
Clinical genetics 2014 Jan 85 (1): 31-5. Ghadirian P, Robidoux A, Nassif E, Martin G, Potvin C, Patocskai E, Younan R, Larouche N, Venne A, Zhang S, Royer R, Narod S |
|
Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2013 Nov 23 (9): 1603-11. Wethington Stephanie L, Park Kay J, Soslow Robert A, Kauff Noah D, Brown Carol L, Dao Fanny, Otegbeye Ebunoluwa, Sonoda Yukio, Abu-Rustum Nadeem R, Barakat Richard R, Levine Douglas A, Gardner Ginger |
|
Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy.
Gynecologic oncology 2013 Feb . Powell CB, Swisher EM, Cass I, McLennan J, Norquist B, Garcia RL, Lester J, Karlan BY, Chen L |
|
HIF-1? overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.
PloS one 2013 8 (2): e56055. van der Groep Petra, van Diest Paul J, Smolders Yvonne H C M, Ausems Margreet G E M, van der Luijt Rob B, Menko Fred H, Bart Joost, de Vries Elisabeth G E, van der Wall Elsk |
|
The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2012 Nov . Mazzola E, Cheng SC, Parmigiani G |
|
Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls.
Gynecologic oncology 2012 Oct 127 (1): 88-93. Mingels Marjanka J J M, Roelofsen Thijs, van der Laak Jeroen A W M, de Hullu Joanne A, van Ham Maaike A P C, Massuger Leon F A G, Bulten Johan, Bol Mij |
|
Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012 Sep 21 (9): 1458-68. Heijnsdijk Eveline A M, Warner Ellen, Gilbert Fiona J, Tilanus-Linthorst Madeleine M A, Evans Gareth, Causer Petrina A, Eeles Rosalind A, Kaas Reinie, Draisma Gerrit, Ramsay Elizabeth A, Warren Ruth M L, Hill Kimberly A, Hoogerbrugge Nicoline, Wasser Martin N J M, Bergers Elisabeth, Oosterwijk Jan C, Hooning Maartje J, Rutgers Emiel J T, Klijn Jan G M, Plewes Don B, Leach Martin O, de Koning Harry |
|
Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.
Cancer 2012 Mar 118 (6): 1515-22. Bayraktar Soley, Elsayegh Nisreen, Gutierrez Barrera Angelica M, Lin Heather, Kuerer Henry, Tasbas Tunc, Muse Kimberly I, Ready Kaylene, Litton Jennifer, Meric-Bernstam Funda, Hortobagyi Gabriel N, Albarracin Constance T, Arun Ba |
|
Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
BJOG : an international journal of obstetrics and gynaecology 2011 Jun 118 (7): 814-24. Manchanda R, Abdelraheim A, Johnson M, Rosenthal A N, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon |
|
BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Dec 28 (36): 5265-73. Rijnsburger Adriana J, Obdeijn Inge-Marie, Kaas Reinoutje, Tilanus-Linthorst Madeleine M A, Boetes Carla, Loo Claudette E, Wasser Martin N J M, Bergers Elisabeth, Kok Theo, Muller Sara H, Peterse Hans, Tollenaar Rob A E M, Hoogerbrugge Nicoline, Meijer Sybren, Bartels Carina C M, Seynaeve Caroline, Hooning Maartje J, Kriege Mieke, Schmitz Paul I M, Oosterwijk Jan C, de Koning Harry J, Rutgers Emiel J T, Klijn Jan G |
|
Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing.
Cancer prevention research (Philadelphia, Pa.) 2010 Dec 3 (12): 1579-85. Hall Michael J, Reid Julia E, Wenstrup Richard |
|
Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Aug 28 (23): 3779-83. Passaperuma Kavitha, Warner Ellen, Hill Kimberley A, Gunasekara Anoma, Yaffe Martin |
|
Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.
Breast cancer research and treatment 2009 Dec 118 (3): 539-46. Shah P, Rosen M, Stopfer J, Siegfried J, Kaltman R, Mason B, Armstrong K, Nathanson K L, Schnall M, Domchek S |
|
Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2008 Oct 34 (10): 1148-54. Isern A E, Loman N, Malina J, Olsson H, Ringberg |
|
BRCA mutations in women with ductal carcinoma in situ.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Jul 13 (14): 4306-10. Smith Karen Lisa, Adank Muriel, Kauff Noah, Lafaro Kelly, Boyd Jeff, Lee Johanna B, Hudis Clifford, Offit Kenneth, Robson Ma |
|
Ductal carcinoma in situ in BRCA mutation carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Feb 25 (6): 642-7. Hwang E Shelley, McLennan Jane L, Moore Dan H, Crawford Beth B, Esserman Laura J, Ziegler John |
|
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006 Oct 15 (10): 1863-70. Haile Robert W, Thomas Duncan C, McGuire Valerie, Felberg Anna, John Esther M, Milne Roger L, Hopper John L, Jenkins Mark A, Levine A Joan, Daly Mary M, Buys Saundra S, Senie Ruby T, Andrulis Irene L, Knight Julia A, Godwin Andrew K, Southey Melissa, McCredie Margaret R E, Giles Graham G, Andrews Lesley, Tucker Katherine, Miron Alexander, Apicella Carmel, Tesoriero Andrea, Bane Anita, Pike Malcolm C, , , Whittemore Alice |
|
The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
PLoS medicine 2006 Jul 3 (7): e217. Stacey Simon N, Sulem Patrick, Johannsson Oskar T, Helgason Agnar, Gudmundsson Julius, Kostic Jelena P, Kristjansson Kristleifur, Jonsdottir Thora, Sigurdsson Helgi, Hrafnkelsson Jon, Johannsson Jakob, Sveinsson Thorarinn, Myrdal Gardar, Grimsson Hlynur Niels, Bergthorsson Jon T, Amundadottir Laufey T, Gulcher Jeffrey R, Thorsteinsdottir Unnur, Kong Augustine, Stefansson Ka |
|
Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.
JAMA 2005 Feb 293 (8): 964-9. Claus Elizabeth B, Petruzella Stacey, Matloff Ellen, Carter Darr |
|
A common missense variant in BRCA2 predisposes to early onset breast cancer.
Breast cancer research : BCR 2005 7 (6): R1023-7. Górski Bohdan, Narod Steven A, Lubinski J |
|
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
JAMA 2004 Sep 292 (11): 1317-25. Warner Ellen, Plewes Donald B, Hill Kimberley A, Causer Petrina A, Zubovits Judit T, Jong Roberta A, Cutrara Margaret R, DeBoer Gerrit, Yaffe Martin J, Messner Sandra J, Meschino Wendy S, Piron Cameron A, Narod Steven |
|
Family history of breast and ovarian cancer and the risk of breast carcinoma in situ.
Breast cancer research and treatment 2003 Mar 78 (1): 7-15. Claus Elizabeth B, Stowe Meredith, Carter Darr |
|
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 Mar 20 (6): 1480-90. Frank Thomas S, Deffenbaugh Amie M, Reid Julia E, Hulick Mark, Ward Brian E, Lingenfelter Beth, Gumpper Kathi L, Scholl Thomas, Tavtigian Sean V, Pruss Dmitry R, Critchfield Gregory |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 13, 2019
- Content source: